Anne‐Marie Lambeir
- Oncology top 0.5%
- Peptidase Inhibition and Analysis 94
- Cellular and Molecular Neuroscience top 0.5%
- Neuropeptides and Animal Physiology 65
-
- Diabetes Treatment and Management 23
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms 16
- Physiology top 1%
- Erythrocyte Function and Pathophysiology 9
-
- Signaling Pathways in Disease 20
- Chemical Synthesis and Analysis 11
-
- Enzyme Structure and Function 11
- Co-authors
- Ingrid De MeesterSimon ScharpéChristine DurinxKoen AugustynsPieter Van der VekenAchiel HaemersJurgen JoossensPaul Proost
- Journals
- Journal of Medicinal Chemistry (15 papers)European Journal of Biochemistry (13 papers)Bioorganic & Medicinal Chemistry Letters (8 papers)
- Partner nations
- BelgiumUnited StatesCanada
In The Last Decade
Anne‐Marie Lambeir
176 papers receiving 7.6k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Oncology 3.8k
- Cellular and Molecular Neuroscience 2.0k
- Endocrinology, Diabetes and Metabolism 1.5k
- Cancer Research 782
- Physiology 207
Countries citing papers authored by Anne‐Marie Lambeir
This map shows the geographic impact of Anne‐Marie Lambeir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Marie Lambeir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Marie Lambeir more than expected).
Fields of papers citing papers by Anne‐Marie Lambeir
This network shows the impact of papers produced by Anne‐Marie Lambeir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Marie Lambeir. The network helps show where Anne‐Marie Lambeir may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anne‐Marie Lambeir, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2020 | 13 | |
| 3 | 2020 | 6 | |
| 4 | 2019 | 12 | |
| 5 | 2018 | 36 | |
| 6 | 2017 | 20 | |
| 7 | 2017 | 139 | |
| 8 | 2016 | 12 | |
| 9 | 2015 | 15 | |
| 10 | 2012 | 47 | |
| 11 | 2008 | 76 | |
| 12 | 2008 | 62 | |
| 13 | 2008 | 41 | |
| 14 | 2006 | 15 | |
| 15 | 2002 | 28 | |
| 16 | 1999 | 97 | |
| 17 | 1998 | 226 | |
| 18 | Comparative properties of a factor-xa inhibitor, 4c2 (an aprotonin analog), heparin and hirudin in a hamster femoral vein platelet-rich mural thrombosis model | 1993 | 2 |
| 19 | 1991 | 72 | |
| 20 | 1989 | 94 |
About Anne‐Marie Lambeir
Anne‐Marie Lambeir is a scholar working on Cellular and Molecular Neuroscience, Oncology and Endocrinology, Diabetes and Metabolism, having authored 177 papers that have together received 7.8k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (94 papers), Neuropeptides and Animal Physiology (65 papers), Diabetes Treatment and Management (23 papers), Signaling Pathways in Disease (20 papers), Protease and Inhibitor Mechanisms (16 papers), Enzyme Structure and Function (11 papers), Chemical Synthesis and Analysis (11 papers) and Erythrocyte Function and Pathophysiology (9 papers). The work is most often cited by research in Oncology (3.8k citations), Cellular and Molecular Neuroscience (2.0k citations) and Endocrinology, Diabetes and Metabolism (1.5k citations). Anne‐Marie Lambeir has collaborated with scholars based in Belgium, United States and Canada. Frequent co-authors include Ingrid De Meester, Simon Scharpé, Christine Durinx, Koen Augustyns, Pieter Van der Veken, Achiel Haemers, Jurgen Joossens, Paul Proost, H. Brian Dunford and Rik K. Wierenga. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Biochemistry, Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.